Results of a clinical trial published in the journal Lancet Infectious Diseases have shown the drug to be effective against non-severe cases of malaria.With the parasite responsible for most malaria cases -- Plasmodium falciparum -- developing resistance to widely-used treatments, researchers have developed a new drug to fight the mosquito-borne disease. The drug, called AQ-13, was able to clear the parasite responsible for the disease within a week, matching the effectiveness of the most widely-used treatment regimen, the study said." The clinical trial results are extraordinarily encouraging," said the study's senior author from a University in New Orleans, Louisiana.
"Compared to the current first-line recommendation for treatment of malaria, the new drug comes out very well," the researcher said. Mosquitoes infected with a parasite spread malaria, causing more than 200 million…